Download Full Volume - United States Renal Data System

BPREVALENCE OF REPORTED ESRD
Reference section B
Table B.5 B.5
Point prevalent rates of of reported ESRD, 2001-2003
patients
patients
alive
alive
on
on
December
December
31
31
of
of
each
each
year,
year,
per
per
million
million
population,
population,
by
by
age,
age,
gender,
gender,
& race
race
ON OUR WEBSITE & CD
Point prevalent rates of reported ESRD, 1998-2000 (B.5.1).
Point prevalent rates of reported ESRD: by primary diagnosis (B.5.2).
330
Unadjusted rates
Rates adjusted for:
Male Female Gender Race Gender &
White Black N Am Asian White Black N Am Asian White Black N Am Asian Male Female race
0-4 32 32 * 15 16 13 * 12 24 22 25 14 31 16 23
5-9 55 62 38 33 39 32 * 19 47 47 24 26 55 37 46
10-14 95 123 114 55 69 94 84 51 82 108 99 53 97 72 84
15-19 168 277 169 139 128 228 137 147 148 252 153 143 181 142 161
20-29 353 1,020 381 371 286 819 472 344 322 943 439 352 449 365 406
30-39 811 3,215 964 763 611 2,149 1,190 645 707 2,668 1,078 710 1,123 818 966
40-49 1,388 6,006 2,421 1,487 930 3,696 1,828 1,311 1,159 4,885 2,147 1,410 2,024 1,326 1,665
50-59 2,211 11,274 5,694 3,044 1,520 7,229 5,012 2,299 1,879 9,410 5,510 2,729 3,524 2,381 2,936
60-64 3,075 15,119 8,496 5,109 2,219 11,912 9,867 3,665 2,637 13,482 9,203 4,370 4,797 3,634 4,201
65-69 3,738 16,260 9,404 5,936 2,758 14,562 12,053 4,614 3,239 15,394 10,749 5,264 5,536 4,486 5,001
70-79 4,429 15,785 7,610 7,512 2,808 14,299 10,118 6,061 3,616 14,945 8,751 6,841 6,099 4,526 5,299
80+ 4,280 11,456 4,707 8,001 1,787 8,547 4,203 5,599 2,944 9,713 4,241 6,623 5,208 2,850 4,009
0-19 89 123 92 61 64 91 66 57 75 107 75 59 91 67 79
20-44 729 2,644 892 696 543 1,822 963 620 617 2,238 949 662 970 704 833
45-64 2,158 10,437 5,167 2,933 1,495 7,005 4,759 2,248 1,922 9,526 5,702 2,866 3,546 2,473 2,995
65-74 3,962 16,238 8,923 6,408 2,814 14,760 11,488 5,134 3,388 15,491 10,128 5,825 5,747 4,582 5,154
75+ 4,472 13,290 5,692 8,078 2,162 10,617 6,420 6,010 3,194 11,242 5,492 6,847 5,552 3,359 4,437
Diabetes 444 1,189 1,066 476 363 1,367 1,350 424 384 1,708 1,759 599 916 783 849
Hypertension 252 1,599 172 342 162 1,069 129 274 194 1,712 220 412 848 486 662
Glomerulonephritis 250 600 286 371 150 392 277 317 194 561 332 370 367 209 286
Other cause 340 575 231 223 273 514 214 248 59 127 57 53 102 70 86
All 1,286 3,963 1,756 1,413 947 3,342 1,970 1,263 1,115 3,638 1,863 1,336 1,637 1,295 1,463
All (age adjusted) 1,309 5,344 2,510 1,872 871 3,954 2,656 1,468 1,068 4,618 2,594 1,647 1,760 1,218 1,463
U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded.
The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.
Age is calculated as of December 31.
*Values for cells with 10 or fewer patients are suppressed.